Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Mahidol University
- Faculty of Medicine Siriraj Hospital, Mahidol University (R2R.635/22)
This publication has 30 references indexed in Scilit:
- Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trialThe Lancet Infectious Diseases, 2022
- COVID-19 Severity in Kidney Transplant Recipients According to Their Postvaccination Serological AssessmentKidney International Reports, 2022
- Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trialsThe Lancet Rheumatology, 2022
- Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workersVaccine: X, 2022
- Risk factors associated with poor response to COVID-19 vaccination in kidney transplant recipientsKidney International, 2021
- Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United StatesAmerican Journal of Kidney Diseases, 2021
- SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virusCommunications Biology, 2021
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialThe Lancet, 2020
- Interpreting Diagnostic Tests for SARS-CoV-2JAMA, 2020
- Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney TransplantationAmerican Journal of Kidney Diseases, 2020